[go: up one dir, main page]

NO983465L - Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser - Google Patents

Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser

Info

Publication number
NO983465L
NO983465L NO983465A NO983465A NO983465L NO 983465 L NO983465 L NO 983465L NO 983465 A NO983465 A NO 983465A NO 983465 A NO983465 A NO 983465A NO 983465 L NO983465 L NO 983465L
Authority
NO
Norway
Prior art keywords
antiestrogens
treatment
pharmaceutical preparations
preparations containing
combination pharmaceutical
Prior art date
Application number
NO983465A
Other languages
English (en)
Other versions
NO983465D0 (no
Inventor
Klaus Stoeckemann
Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO983465D0 publication Critical patent/NO983465D0/no
Publication of NO983465L publication Critical patent/NO983465L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO983465A 1996-01-29 1998-07-28 Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser NO983465L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19604231A DE19604231A1 (de) 1996-01-29 1996-01-29 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
PCT/EP1997/000395 WO1997027863A1 (de) 1996-01-29 1997-01-29 Pharmazeutisches kombinationspräparat aus lhrh-analoga und antiöstrogenen zur behandlung von gynäcologischen störungen

Publications (2)

Publication Number Publication Date
NO983465D0 NO983465D0 (no) 1998-07-28
NO983465L true NO983465L (no) 1998-09-18

Family

ID=7784640

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983465A NO983465L (no) 1996-01-29 1998-07-28 Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser

Country Status (20)

Country Link
US (3) US7309691B2 (no)
EP (1) EP0877621A1 (no)
JP (1) JP2000505422A (no)
KR (1) KR19990082080A (no)
CN (1) CN1209750A (no)
BG (1) BG63248B1 (no)
BR (1) BR9707210A (no)
CZ (1) CZ239198A3 (no)
DE (1) DE19604231A1 (no)
EA (1) EA001178B1 (no)
HU (1) HUP9901288A3 (no)
IL (1) IL125557A0 (no)
MX (1) MX9806082A (no)
NO (1) NO983465L (no)
PL (1) PL328066A1 (no)
SK (1) SK98798A3 (no)
TR (1) TR199801452T2 (no)
TW (1) TW577735B (no)
WO (1) WO1997027863A1 (no)
ZA (1) ZA97741B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
DK1082129T3 (da) * 1998-04-23 2004-01-26 Zentaris Gmbh Fremgangsmåde til behandling af fertilitetsdefekt
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
PT1229906E (pt) * 1999-08-31 2008-01-18 Bayer Schering Pharma Ag Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos
AU769482B2 (en) * 1999-09-23 2004-01-29 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
AU2001269439A1 (en) * 2000-07-05 2002-01-14 Takeda Chemical Industries Ltd. Medicinal preparations for treating sex hormone-dependent diseases
DE10050831A1 (de) 2000-10-05 2002-05-02 Veyx Pharma Gmbh Verfahren zum Zyklusstart bei weiblichen Zuchttieren
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist/antagonist for the manufacture of a medicament for treating vaginitis
AU2002235348A1 (en) * 2001-01-17 2002-07-30 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
ATE498408T1 (de) * 2001-08-10 2011-03-15 Takeda Pharmaceutical Gnrh-agonistische kombinationsmittel
WO2006098371A1 (ja) * 2005-03-16 2006-09-21 Masao Igarashi 子宮内膜症および子宮腺筋症の治療剤および予防剤
EP2266567A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
EP2266568A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
KR20170127044A (ko) 2010-06-16 2017-11-20 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US5451590A (en) * 1993-12-21 1995-09-19 Eli Lilly & Co. Methods of inhibiting sexual precocity
US5451589A (en) * 1993-12-21 1995-09-19 Eli Lilly And Company Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
US5455275A (en) * 1994-05-11 1995-10-03 Eli Lilly And Company Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration

Also Published As

Publication number Publication date
US20010041672A1 (en) 2001-11-15
BG102660A (en) 1999-06-30
US7309691B2 (en) 2007-12-18
SK98798A3 (en) 1999-03-12
IL125557A0 (en) 1999-03-12
CN1209750A (zh) 1999-03-03
TW577735B (en) 2004-03-01
WO1997027863A1 (de) 1997-08-07
DE19604231A1 (de) 1997-07-31
KR19990082080A (ko) 1999-11-15
US20020198155A1 (en) 2002-12-26
TR199801452T2 (xx) 1998-10-21
PL328066A1 (en) 1999-01-04
BG63248B1 (bg) 2001-07-31
EA199800666A1 (ru) 1999-02-25
CZ239198A3 (cs) 1998-11-11
NO983465D0 (no) 1998-07-28
ZA97741B (en) 1997-07-30
HUP9901288A2 (hu) 1999-08-30
EP0877621A1 (de) 1998-11-18
US20020032156A1 (en) 2002-03-14
MX9806082A (es) 1998-10-31
HUP9901288A3 (en) 2000-03-28
JP2000505422A (ja) 2000-05-09
BR9707210A (pt) 1999-04-06
EA001178B1 (ru) 2000-10-30

Similar Documents

Publication Publication Date Title
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
EP0979225A4 (en) COMPOUNDS AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE AGENTS
DE69807634D1 (de) Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen
NO983465L (no) Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
HUP0001442A3 (en) Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
CS553490A3 (en) Transdermal therapeutic system
DE69315257D1 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
DK19893D0 (da) Praeparat til nasal behandling
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
NO20003229D0 (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
ATE247466T1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
NO953003D0 (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DE69732974D1 (de) 5-phenyl-3-pyridazinon-derivate und diese enthaltende arzneimittelzubereitungen
GB9615710D0 (en) Pharmaceutical preparations for the treatment of sarcocystosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application